Kleresca® Strengthens Scientific Proof of Fluorescent Light Energy (FLE) in New StudyAllbiopro2019-07-05T10:58:25+09:007월 5th, 2019|
European Society of Cardiology Hosting Cutting-edge Digital SummitAllbiopro2019-07-05T10:57:50+09:007월 5th, 2019|
Alive Hospice, Notice of Data Privacy Event – July 3, 2019Allbiopro2019-07-05T10:57:16+09:007월 5th, 2019|
After Rocky Road, Karyopharm Wins FDA Approval for Multiple Myeloma DrugAllbiopro2019-07-05T10:56:43+09:007월 5th, 2019|
U.S. Pharma and Biotech Companies Develop Therapies that Lead to ‘Health Independence.’Allbiopro2019-07-05T10:56:10+09:007월 5th, 2019|
Fujifilm investing $30m into cell culture media plant in NetherlandsAllbiopro2019-07-05T10:55:35+09:007월 5th, 2019|
Study finds electronic cigarettes damage brain stem cellsAllbiopro2019-07-05T10:54:26+09:007월 5th, 2019|
Life science start-up Pantherna Therapeutics receives 7-digit investmentAllbiopro2019-07-05T10:53:18+09:007월 5th, 2019|
AgaMatrix, Inc. And WaveForm Technologies, Inc. Complete $56 Million Capital RaiseAllbiopro2019-07-04T09:40:11+09:007월 4th, 2019|
Senseonics Announces Equity Grants To Employees Under Inducement PlanAllbiopro2019-07-04T09:39:14+09:007월 4th, 2019|
FDA approves new treatment for refractory multiple myelomaAllbiopro2019-07-04T09:38:19+09:007월 4th, 2019|
ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)Allbiopro2019-07-04T09:37:24+09:007월 4th, 2019|
